Recent breakthroughs in herbal cubosome technology offer promising solutions for arthritis treatment, improving bioavailability and reducing side effects through advanced nanotechnology. Cutting-edge ...
Recent studies reveal urolithin A from pomegranate enhances mitochondrial function, improving exercise tolerance in statin users by 18% over 8 weeks. New research shows pomegranate-derived urolithin A...
The first human pilot study on intravenous BPC-157 demonstrates safety and tolerability, while preclinical data suggests potential in gut health, wound healing, and neuroprotection. The synthetic pept...
New research highlights the role of omega-3s, vitamin D, and personalized diets in managing endocrine therapy side effects, with AI offering tailored solutions. Emerging studies show personalized nutr...
Cubosome technology improves delivery of anti-inflammatory herbal compounds like curcumin and boswellia, offering a promising alternative to conventional arthritis drugs with fewer side effects. Advan...
Recent studies show NLC-encapsulated curcumin and EGCG significantly improve skin retention and SIRT1 expression, offering promising anti-aging benefits. NLC-encapsulated curcumin and EGCG show enhanc...
A clinical trial at UC San Diego investigates how time-restricted eating may slow Huntington’s disease progression by improving metabolic health and reducing neuroinflammation. Researchers launc...
New cubosome technology delivers curcumin and resveratrol with unprecedented efficiency, showing 40% better inflammation reduction than conventional treatments in recent trials. Breakthrough cubosome ...
Recent studies reveal that combining curcumin and EGCG in nanostructured lipid carriers enhances antioxidant effects by 40%, offering promising anti-aging solutions. New research demonstrates the powe...
Recent pilot studies indicate BPC-157 may safely accelerate healing of tendon and muscle tears, though FDA approval is pending and WADA monitors its use in sports. Emerging research on the peptide BPC...
